Regeneus Ltd announced a private placement to issue 580,193,928 shares at an issue price of AUD 0.006 per share for the gross proceeds of AUD 3,480,000 on April 5, 2024. The transaction will include participation from new investors Orient EuroPharma for 238,435,861 shares, Zheng Yang Biomedical Technology for 238,435,861 shares, Tseng, Yu-Hung (Sebastian) for 23,843,586 shares, Chiu, Li-Chien for 47,687,172 shares and Chiu, Mu-Ni for 31,791,448 shares. The company is expected to receive in 2 tranches as tranche 1 for 153,218,457 shares for AUD 919,311 and tranche 2 for 426,975,471 shares for AUD 2,561,853.

The tranche 1 is expected to receive on April 9, 2024. The tranche 2 s subject to shareholder approvals to issue New Shares, including for the purpose. The transaction is subject to general shareholders which is to be held on May 24, 2024.